Which beta 2 agonist is not given for acute bronchial asthma
First, I need to recall the different beta-2 agonists and their uses. Beta-2 agonists are bronchodilators used in asthma. There are short-acting and long-acting types. Acute asthma attacks require quick relief, so short-acting beta-2 agonists (SABAs) like albuterol (salbutamol) are the go-to. They work by relaxing the bronchial smooth muscles quickly.
Long-acting beta-2 agonists (LABAs), such as salmeterol, are used for maintenance in chronic asthma, not acute attacks. Using LABAs alone in an acute setting isn't effective because they take longer to act and aren't sufficient for immediate relief. They're usually combined with inhaled corticosteroids for long-term control.
Now, looking at the options (though they aren't listed here), the distractors would be SABAs like albuterol, terbutaline, or maybe formoterol. The correct answer is salmeterol because it's a LABA.
Wait, formoterol is a LABA too, but it's sometimes used in combination with corticosteroids as a reliever in some guidelines. Hmm, but the question is about what's not given in acute settings. Salmeterol is definitely a LABA and not used acutely. The other options might include other SABAs.
So the core concept is the distinction between SABAs and LABAs. The correct answer is the LABA, which isn't used for acute relief. The incorrect options would be SABAs. Also, maybe formoterol is a tricky one because it can be used in some acute scenarios when combined with corticosteroids, but generally, it's a LABA. However, the main answer here is salmeterol.
**Core Concept** Beta-2 agonists are classified as short-acting (SABAs) or long-acting (LABAs). SABAs like albuterol are first-line for acute bronchial asthma due to rapid bronchodilation, while LABAs like salmeterol are maintenance therapies and ineffective in acute exacerbations.
**Why the Correct Answer is Right** Salmeterol is a long-acting beta-2 agonist (LABA) with a slow onset (20–30 minutes) and duration of 12 hours. It lacks the rapid bronchodilation needed in acute asthma, where short-acting agents (e.g., albuterol) are required to relieve acute bronchospasm. LABAs are contraindicated as monotherapy in acute settings due to risk of uncontrolled asthma.
**Why Each Wrong Option is Incorrect**
**Option A:** *Albuterol* is a short-acting beta-2 agonist (SABA) and the first-line treatment for acute asthma.
**Option B:** *Terbutaline* is another SABA used in acute bronchospasm.
**Option D:** *Formoterol* is a long-acting beta-2 agonist (LABA) but is sometimes used in combination with inhaled corticosteroids for asthma maintenance, not acute relief